K. Michael Conaway
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what has K. Michael Conaway bought and sold in the last 12 months? Show the disclosed ranges and the filings.
Using 13F.ai, which stocks does K. Michael Conaway trade most often, and how did those trades do against the S&P 500?
Using 13F.ai, list K. Michael Conaway's recent trades alongside any government contracts, lobbying filings or bills involving the same companies, with dates.
Connect your AI · Plans and the 7-day free trial (card required)
Buying vs selling by year
Estimated dollars bought and sold each year, based on the ranges members disclose.
Loading…
Committees
The congressional committees and subcommittees this member sits on.
We list committee seats for current members only.
Campaign money
What this member's campaign committees raised and spent in the latest election cycle, from reports filed with the Federal Election Commission.
| Raised | Spent | Cash on hand | Debts |
|---|---|---|---|
| $3,580 | $36,908 | $19,760 | — |
2026 cycle (January 2025 to December 2026), reports through Sep 30, 2026. Candidate page on FEC.gov ↗
2024 cycle: raised $1,053, spent $24.9K, cash on hand $53.1K. FEC.gov ↗
Totals for the whole two-year cycle, not one election. Raised includes transfers between a candidate's own committees. Totals only: no individual donor is named or shown.
Net worth
2019 reportAn estimate from the member's annual financial disclosure, as a range. The form reports value ranges, not exact figures.
From the 2019 annual report: 290 assets and 0 liabilities listed. The range is wide because every asset and debt is counted at the lowest and highest end of its bracket.
| The form reports value brackets, not exact figures. Low counts every asset at the bottom of its bracket and every debt at the top; high is the reverse; the middle (midpoint estimate) uses the middle of every bracket. The range is wide because it adds up every bracket. | Report | |||||
|---|---|---|---|---|---|---|
| 2019 | $7.0M | $13.3M | $19.6M | 290 | 0 | PDF ↗ |
| 2018 | $6.3M | $12.4M | $18.5M | 227 | 0 | PDF ↗ |
| 2017 | $6.3M | $12.4M | $18.4M | 239 | 0 | PDF ↗ |
| 2015 | $5.0M | $11.3M | $17.7M | 493 | 0 | Amendment PDF ↗ |
Estimated from the member's annual disclosure: assets minus liabilities, using the reported value ranges. Excludes the primary residence. Not audited.
Trades
Every trade this member, their spouse or dependent children have disclosed, newest first unless you sort by another column.
| Stock | Asset type | Transaction | Filed | Traded | Since tradeHow the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss. | Comment | Filing |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group Incorporated | — | Purchase $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| UNH UnitedHealth Group Incorporated | — | Purchase $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| TMO Thermo Fisher Scientific Inc | — | Sale $15,001 - $50,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| KHC The Kraft Heinz Company | — | Sale $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| KHC The Kraft Heinz Company | — | Sale $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| PM Philip Morris International Inc | — | Sale $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| PM Philip Morris International Inc | — | Sale $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| AXP American Express Company | — | Purchase $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| AXP American Express Company | — | Purchase $1,001 - $15,000 Spouse sP M81 (Merrill Lynch) | Apr 2, 2017 | Mar 24, 2017 | — | PDF ↗ | |
| Uit FRIsT Trust Equity INCoME PoRTFoLIo sER 54 MoNTHLY | — | Purchase $15,001 - $50,000 Spouse sP E62 (Edward Jones) | Apr 2, 2017 | Mar 21, 2017 | — | UIT FRIsT TRUsT EQUITY INCoME PoRTFoLIo sER 54 MoNTHLY | PDF ↗ |
| R2000 Arn IssUER sEK Cap 14.28% sV 1,217.325 Due 09/29/17 | — | Purchase $50,001 - $100,000 Spouse sP M40 (Merrill Lynch) | Apr 2, 2017 | Mar 15, 2017 | — | R2000 ARN IssUER sEK CAP 14.28% sV 1,217.325 DUE 09/29/17 | PDF ↗ |
| R2000 Arn IssUER sEK Cap 13.83% sV 1,237.751 Due 11/22/17 | — | Purchase $50,001 - $100,000 Spouse sP M40 (Merrill Lynch) | Apr 2, 2017 | Mar 15, 2017 | — | R2000 ARN IssUER sEK CAP 13.83% sV 1,237.751 DUE 11/22/17 | PDF ↗ |
| Indu bUF Cap Part NTs Cap 66.45% sV 17,900.10 Due 12/27/19 bUF 30.00% | — | Sale $50,001 - $100,000 Spouse sP M40 (Merrill Lynch) | Apr 2, 2017 | Mar 15, 2017 | — | INDU bUF CAP PART NTs CAP 66.45% sV 17,900.10 DUE 12/27/19 bUF 30.00% | PDF ↗ |
| Djia Lirn IssUER RbC Part 111.30% sV 16,846.1 Due 06/28/19 | — | Sale $15,001 - $50,000 Spouse sP M40 (Merrill Lynch) | Apr 2, 2017 | Mar 15, 2017 | — | DJIA LIRN IssUER RbC PART 111.30% sV 16,846.1 DUE 06/28/19 | PDF ↗ |
| Uit FIRsT Trust sER 24 International Cap sTRENgTH PoRT | — | Sale $15,001 - $50,000 Spouse sP E62 (Edward Jones) | Apr 2, 2017 | Mar 7, 2017 | — | UIT FIRsT TRUsT sER 24 INTL CAP sTRENgTH PoRT Redemption | PDF ↗ |
| R2000 Clirns Issuer Cibc CaP 20.40% SV 1,075.699 Due 03/28/18 | — | Purchase $50,001 - $100,000 Spouse SP M40 (Merrill Lynch) | Mar 2, 2017 | Feb 17, 2017 | — | R2000 CLIRNS ISSUER CIBC CaP 20.40% SV 1,075.699 DUE 03/28/18 | PDF ↗ |
| R2000 Clirns Issuer Cibc CaP 20.40% SV 1,075.699 Due 03/28/18 | — | Purchase $15,001 - $50,000 Spouse SP M40 (Merrill Lynch) | Mar 2, 2017 | Feb 6, 2017 | — | R2000 CLIRNS ISSUER CIBC CaP 20.40% SV 1,075.699 DUE 03/28/18 | PDF ↗ |
| INNaTE IMMUNoTHERaPEUTIC aUD PaR oRDINaRY | — | Purchase $1,001 - $15,000 Joint account JT M39 (Merrill Lynch) | Mar 2, 2017 | Feb 3, 2017 | — | INNaTE IMMUNoTHERaPEUTIC aUD PaR oRDINaRY | PDF ↗ |
| SP500 Stepup Issuer HSBC Step 35.00% | — | Purchase $50,001 - $100,000 Spouse SP M40 (Merrill Lynch) | Feb 6, 2017 | Jan 26, 2017 | — | SP500 STEPUP ISSUER HSBC STEP 35.00% | PDF ↗ |
| SP500 Stepup Issuer HSBC Step 35.00% | — | Purchase $15,001 - $50,000 Spouse Trust W66 (Wells Fargo) | Feb 6, 2017 | Jan 26, 2017 | — | SP500 STEPUP ISSUER HSBC STEP 35.00% | PDF ↗ |
| R2000 Stepup Issuer Barc Step 35.00% | — | Purchase $15,001 - $50,000 Spouse SP M40 (Merrill Lynch) | Feb 6, 2017 | Jan 26, 2017 | — | R2000 STEPUP ISSUER BARC STEP 35.00% | PDF ↗ |
| Innate Immunotherapeutic Aud Par Ordinary | — | Purchase $1,001 - $15,000 Joint account JT M39 (Merrill Lynch) | Feb 6, 2017 | Jan 26, 2017 | — | INNATE IMMUNOTHERAPEUTIC AUD PAR ORDINARY | PDF ↗ |
| Wells Fargo & Company JR Subordntd Ser | — | Sale $15,001 - $50,000 Spouse SP M37 (Merrill Lynch) | Feb 6, 2017 | Jan 19, 2017 | — | WELLS FARGO & COMPANY JR SUBORDNTD SER | PDF ↗ |
| US Bancorp JR Subordntd | — | Sale $15,001 - $50,000 Spouse SP M37 (Merrill Lynch) | Feb 6, 2017 | Jan 19, 2017 | — | US BANCORP JR SUBORDNTD | PDF ↗ |
| SPX/SX5E Stepup Iss HSBC Step 22.80% | — | Purchase $50,001 - $100,000 Spouse SP M37 (Merrill Lynch) | Feb 6, 2017 | Jan 19, 2017 | — | SPX/SX5E STEPUP ISS HSBC STEP 22.80% | PDF ↗ |
Returns describe the stock since the trade date, not the member’s actual result. Information, not investment advice.
Trades in companies under their committees' jurisdiction
Trades in a company whose industry falls under a committee or subcommittee this member sits on.
No recent committee overlap for this member.
Capitol Hires from K. Michael Conaway’s office
16 hiresLobbyists for public companies who say they once worked in K. Michael Conaway’s office, from their lobbying filings.
| The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|
| OXY Occidental Petroleum Corporation | Jeff Burton | Chief of Staff | Burton Strategy Group | Report period 2026 Q3 ↗ Posted Oct 26, 2026 · in 8 filings |
| GAP Gap, Inc. | Mark Williams | Chief of Staff | Ferox Strategies | Report period 2026 Q3 ↗ Posted Oct 19, 2026 |
| FTNT Fortinet, Inc. | Sarah (Beatty) Rogers | Sr. Legislative Assistant | Navigators Global LLC (formerly DC Navigators, LLC) | Report period 2026 Q1 ↗ Posted Apr 21, 2026 · in 2 filings |
| APTV Aptiv plc | Mark Williams | Chief of Staff | Ferox Strategies | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 2 filings |
| RNA Atrium Therapeutics, Inc. | Mark Williams | Chief of Staff | Ferox Strategies | Report period 2026 Q1 ↗ Posted Apr 17, 2026 · in 2 filings |
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered.
Bills sponsored
The ten most recent bills and resolutions this member introduced.
No recent sponsored bills for this member. We list sponsored bills for current members only.
Recent votes
The latest recorded votes this member took part in, with how they voted.
Loading…
Votes on bills they sponsored
Recorded votes on the bills and resolutions this member introduced, newest first.
Loading…
Terms served
Each term in office, with the seat and party at the time.
| Jan 3, 2019 | Jan 3, 2021 | House | TX-11 | Republican |
| Jan 3, 2017 | Jan 3, 2019 | House | TX-11 | Republican |
| Jan 6, 2015 | Jan 3, 2017 | House | TX-11 | Republican |
| Jan 3, 2013 | Jan 3, 2015 | House | TX-11 | Republican |
| Jan 5, 2011 | Jan 3, 2013 | House | TX-11 | Republican |
| Jan 6, 2009 | Jan 3, 2011 | House | TX-11 | Republican |
| Jan 4, 2007 | Jan 3, 2009 | House | TX-11 | Republican |
| Jan 4, 2005 | Jan 3, 2007 | House | TX-11 | Republican |